/   Home   /   Newsroom   /   Research in China

China, U.S. Develop New MERS Treatment

Jun 16, 2015     Email"> PrintText Size

Chinese and American scientists have jointly developed a new antibody targeting the Middle East Respiratory Syndrome (MERS) virus, which has killed 16 people and landed 150 others in hospital.

Fudan University, which worked with U.S. National Institutes of Health to develop the antibody, said on Monday that tests on animals had seen "very effective" results.

Jiang Shibo, who led the research team at Fudan, said the m336 antibody could neutralize MERS virus more effectively than other antibodies.

Zhong Nanshan, a renowned respiratory expert, called for an immediate clinical trial.

The m336 antibody treatment has proved more effective when coupled with a specific type of polypeptide, according to Jiang. (Xinhua)


(Editor: CHEN Na)



Related Articles

MERS; Middle East respiratory syndrome; antibody; George GAO Fu

China, US Spearhead MERS Fight

Jun 17, 2015

Chinese and US scientists have jointly developed a new antibody targeting the Middle East respiratory syndrome virus, which has killed 19 people and put more than 150 in hospitals. The antibody has proved highly successful on animals, and experts have called for a clinica...

MERS; Middle East Respiratory Syndrome; bats; mutation

UMN Scientists Identify 2 Mutations Critical for MERS Transmission from Bats to Humans

Jun 15, 2015

Researchers have identified two critical mutations allowing the deadly Middle East Respiratory Syndrome (MERS) virus to transmit from bats to humans. The findings were published in the most recent edition of the Journal of Virology. In this new study, researchers...

Contact Us

Copyright © 2002 - Chinese Academy of Sciences